DRG International | Overview
 

Overview

Home » Overview

 

Overview

DRG International, Inc. is a leading specialty medical diagnostics and equipment manufacturer, and distributor with operations in more than 110 countries. Founded in 1970, DRG International provides a complete range of products and services to the diagnostics and cardiology-related medical community. DRG International’s global headquarters is based in Mountainside, New Jersey.

Sales

Estimated Annual Sales: $50 million

  • The majority of DRG® sales are in cardiology and cardio-surgery products and equipment and in immunodiagnostics
  • DRG® sales are worldwide. Strong markets are throughout Western Europe, Eastern Europe, Poland, the US, the Middle East, and China

 

Employees

  • DRG International employees approximately 120 people worldwide

President and CEO

  • Dr. Cyril E. Geacintov

Office Locations

DRG® has offices and operations across the globe, including:

  • United States

    •     DRG International Global Headquarters

  • Germany

    •     DRG Instruments GmbH, R&D and Production — Marburg, Germany

  • Russia

    •     DRG Techsystems, DRG International Service Branch — Moscow, Russia

    •     DRG Biomed — St. Petersburg, Russia

  • Poland

    •      DRG MEDTEK — Warsaw, Poland

    •      DRG MEDTEK Field Office — Gliwice, S. Poland

  • Czech Republic

    •      DRG Spol. S.R.O. — Brno, Czech Republic

  • China

    •      DRG Intl.-China Rep. Office — Beijing, China

  • Croatia

    • DRG Elstim Rep. Office — Zagreb, Croatia

 

Products/Services

DRG International offers various laboratory immunodiagnostic products and equipment. In addition, DRG®, in cooperation with major U.S. and foreign suppliers, is a leading distributor for cardiac, electrophysiology, and angiology equipment and supplies in certain markets.
DRG® provides a complete range of services including delivery, customs clearance, installation, on-site training and technical support
as well as after-warranty service.

 

   
  • Ultrasound Med Diagnostic Equipment
   

 

Product Development

Currently, DRG International has new products under development, including:

  • CTGF (Liver Fibrosis)
  • CYR/NOV-preeclampsia
  • eCadherin–gastric cancer
  • L1- ovarian carcinoma
  • Lactate Saliva Elisa
  • PMSG Rapid Screen test
  • Renin Elisa
     

Current Projects/Initiatives

  • Combined Chemistry/Immunology Automatic Readers

  • Zentrilab microarray

  • Treponema Screen

  • Bladder Cancer Screen

  • Infectious disease tests

  • Automatic readers

Philanthropy/Board Memberships

  • Russian Nobility in America Association, Inc.

  • Russian Children’s Welfare Society, Inc.

  • Tolstoy Foundation Nursing Home Company, Inc.

University Projects

DRG® is involved in University projects at universities across the globe, including:

  • University of Wurzburg, Germany

  • University of Tennessee, Tennessee, USA

  • University Munchen, Germany

  • University Marburg, Germany

Return to Home Page   |   Return to the Top of this Page